Bioscience Animal Book Value Per Share vs. Shares Owned By Insiders

BIS Stock   3.30  0.02  0.61%   
Taking into consideration Bioscience Animal's profitability measurements, Bioscience Animal Health may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Bioscience Animal's ability to earn profits and add value for shareholders.
For Bioscience Animal profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioscience Animal to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioscience Animal Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioscience Animal's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioscience Animal Health over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Bioscience Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioscience Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioscience Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bioscience Animal Health Shares Owned By Insiders vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bioscience Animal's current stock value. Our valuation model uses many indicators to compare Bioscience Animal value to that of its competitors to determine the firm's financial worth.
Bioscience Animal Health is number one stock in book value per share category among its peers. It also is number one stock in shares owned by insiders category among its peers making about  35.27  of Shares Owned By Insiders per Book Value Per Share. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioscience Animal's earnings, one of the primary drivers of an investment's value.

Bioscience Shares Owned By Insiders vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Bioscience Animal

Book Value per Share

 = 

Common Equity

Average Shares

 = 
2.38 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Bioscience Animal

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
84.04 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Bioscience Shares Owned By Insiders Comparison

Bioscience Animal is currently under evaluation in shares owned by insiders category among its peers.

Bioscience Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bioscience Animal. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioscience Animal position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioscience Animal's important profitability drivers and their relationship over time.

Use Bioscience Animal in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioscience Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioscience Animal will appreciate offsetting losses from the drop in the long position's value.

Bioscience Animal Pair Trading

Bioscience Animal Health Pair Trading Analysis

The ability to find closely correlated positions to Bioscience Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioscience Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioscience Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioscience Animal Health to buy it.
The correlation of Bioscience Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioscience Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioscience Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioscience Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bioscience Animal position

In addition to having Bioscience Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Growth Funds Thematic Idea Now

Large Growth Funds
Large Growth Funds Theme
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bioscience Stock

To fully project Bioscience Animal's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioscience Animal Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioscience Animal's income statement, its balance sheet, and the statement of cash flows.
Potential Bioscience Animal investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bioscience Animal investors may work on each financial statement separately, they are all related. The changes in Bioscience Animal's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioscience Animal's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.